From: Validation of self-administered tests for screening for chronic pregnancy-related pelvic girdle pain
Self-administered test | Number of positive tests | |||||||
---|---|---|---|---|---|---|---|---|
Total n = 289 | PGP n = 51 | No PGP n = 238 | p-value between groups | Sensi-tivity | Speci-ficity | NPV | PPV | |
Tests for anterior pgp | ||||||||
Trendelenburg, symphyseal pain | 16 (5.5%) | 9 (17.6%) | 7 (2.9%) | 0.001 | 17.6 | 2.9 | 84.6 | 56.3 |
MAT | 24 (8.3%) | 12 (23.5%) | 12 (5.0%) | < 0.001 | 23.5 | 5.0 | 85.3 | 50.0 |
Tests for posterior pgp | ||||||||
Trendelenburg, posterior pain | 46 (15.9%) | 25 (49.0%) | 21 (8.8%) | < 0.001 | 49.0 | 8.8 | 84.8 | 54.3 |
P4 | 68 (23.5%) | 29 (56.9%) | 39 (16.3%) | < 0.001 | 56.9 | 16.4 | 90.0 | 42.6 |
Bridging | 60 (20.8%) | 29 (56.9%) | 31 (13.0%) | < 0.001 | 56.9 | 13.0 | 90.4 | 48.3 |
Patrick Faber | 80 (27.7%) | 31 (60.8%) | 49 (20.6%) | < 0.001 | 60.8 | 20.5 | 90.9 | 51.7 |
Total number of positive PGP tests, 0–12 | 0 (0–12) | 4 (0–12) | 0 (0–12) | < 0.001 | ||||
Additional tests | ||||||||
ASLR, pain | 66 (22.8%) | 30 (58.8%) | 36 (15.1%) | < 0.001 | 58.8 | 15.1 | 82.9 | 100 |
ASLR, difficulty | 0 (0–8) | 2 (0–8) | 0 (0–6) | < 0.001 | ||||
Modified SLR | 21 (7.3%) | 11 (21.6%) | 10 (4.2%) | < 0.001 | 21.6 | 4.2 | 85.1 | 52.4 |